Wikipedia -WSS

Wikipedia

author：focus 2025-10-02 00:52:29 - browse：35

Illumina, the largest maker of DNA-sequencing technology and a storied name in the biotechnology industry, named Jacob Thaysen, a 10-year-veteran at life sciences-tools firm Agilent, as its new CEO.

The appointment follows a bitter board fight that ended with the departure of Francis deSouza, who had been Illumina’s CEO since 2016. The battle, tipped off by Illumina’s troubled acquisition of cancer diagnostics firm Grail, had involved a proxy fight staged by activist investor Carl Icahn.

During the battle, there had been speculation that Jay Flatley, deSouza’s predecessor, could return. Under Flatley, Illumina had grown from an upstart to the dominant player in a field that has proved pivotal for medical research and delivered sizable returns to investors.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Why the drug industry's warnings on the IRA's impact fall short

leisure time

knowledge

WSS

Grad students accuse University of California of wage theft

Eli Lilly CEO gives to Mike Pence presidential super PAC

Steward Health Care files for bankruptcy

FDA panel to weigh safety of artificial wombs for preterm births

Use wet bulb globe temperature, not heat index, to protect workers

Midwives could help bridge maternal health disparities in the U.S.

entertainment

Wikipedia

hotspot

Sports medicine is finally prioritizing gender equality

Neurocrine congenital adrenal hyperplasia trial succeeds

Novavax promises a turnaround & Lilly roils the obesity market

Information blocking fines are now fair game in health care

BioMarin wins approval for gene therapy to treat hemophilia A

FDA weighs limits of animal data in assessing artificial wombs

Continuity nursing helped my family in our darkest PICU moments

Assistant physicians can help address the primary care shortage

New air purifier tech could be key to improving indoor air quality

Chamber of Commerce, DOJ clash in court over drug prices

knowledge

PBMs drew scrutiny in House hearing — and so did pharma

H5N1 bird flu: what we're starting to learn about infection in cows

First recipient of genetically engineered pig kidney has died

How to improve immunocompromised access to mAb treatments

What happened to the House vote on health price transparency?

How the messy conversation about Dolly changed bioethics

entertainment

leisure time

knowledge

hotspot